This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Clément, S. Articles by Schurmans, S. Search for Related Content PubMed PubMed Citation Articles by Clément, S. Articles by Schurmans, S. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB IODINE LEVOTHYROXINE

Low TSH Requirement and Goiter in Transgenic Mice Overexpressing IGF-I and IGF-I Receptor in the Thyroid Gland

Institut de Recherche Interdisciplinaire en Biologie Humaine et Nucléaire, Institut de Biologie et de Médecine Moléculaire, Université Libre de Bruxelles (S.C., B.R., J.E.D., S.S.), 6041 Gosselies, Belgium; Departments of Medicine and Pediatrics, University of Chicago (S.R.), Chicago, Illinois 60637

Address all correspondence and requests for reprints to: Dr. Serge Clément, Institut de Recherche Interdisciplinaire en Biologie Humaine et Nucléaire, Institut de Biologie et de Médecine Moléculaire, Université Libre de Bruxelles, 6041 Gosselies, Belgium. E-mail: sclement{at}ulb.ac.be

Through the cAMP signaling pathway, TSH stimulates thyroid follicular cell proliferation, differentiation, and function. Although the autocrine production of IGF-I in the thyroid gland suggests an important physiological function for this factor in these processes, the exact role of the IGF-I/IGF-I receptor system in vivo remains unclear. Although the mitogenic action of TSH requires the presence of IGF-I or insulin in primary culture of dog and human thyroid cells, IGF-I has an effect equal to and independent of the effect of TSH on cell proliferation in rat thyroid cell lines and may even be the main growth regulator in this case. To investigate the in vivo function of the IGF-I/IGF-I receptor system, transgenic mice overexpressing human IGF-I, IGF-I receptor, or both in the thyroid were generated. Adult transgenic mice did not present external signs of thyroid dysfunction, but mice overexpressing both transgenes had significantly increased gland weight and follicular lumen area. A decreased TSH level together with a slightly increased serum T₄ concentration and increased thyroidal iodine uptake were also observed, suggesting that IGF-I and IGF-I receptor stimulate thyroid function to some extent in vivo.

This article has been cited by other articles:

				S. Tsui, V. Naik, N. Hoa, C. J. Hwang, N. F. Afifiyan, A. Sinha Hikim, A. G. Gianoukakis, R. S. Douglas, and T. J. Smith Evidence for an Association between Thyroid-Stimulating Hormone and Insulin-Like Growth Factor 1 Receptors: A Tale of Two Antigens Implicated in Graves' Disease J. Immunol., September 15, 2008; 181(6): 4397 - 4405. [Abstract] [Full Text] [PDF]

				H. Filipsson, E. Nystrom, and G. Johannsson Exploring the use of recombinant human TSH in the diagnosis of central hypothyroidism Eur. J. Endocrinol., August 1, 2008; 159(2): 153 - 160. [Abstract] [Full Text] [PDF]

				T. Fukushima, T. Nedachi, H. Akizawa, M. Akahori, F. Hakuno, and S.-I. Takahashi Distinct Modes of Activation of Phosphatidylinositol 3-Kinase in Response to Cyclic Adenosine 3', 5'-Monophosphate or Insulin-Like Growth Factor I Play Different Roles in Regulation of Cyclin D1 and p27Kip1 in FRTL-5 Cells Endocrinology, July 1, 2008; 149(7): 3729 - 3742. [Abstract] [Full Text] [PDF]

				H. Volzke, N. Friedrich, S. Schipf, R. Haring, J. Ludemann, M. Nauck, M. Dorr, G. Brabant, and H. Wallaschofski Association between Serum Insulin-Like Growth Factor-I Levels and Thyroid Disorders in a Population-Based Study J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 4039 - 4045. [Abstract] [Full Text] [PDF]

				M. M. Norden, F. Larsson, S. Tedelind, T. Carlsson, C. Lundh, E. Forssell-Aronsson, and M. Nilsson Down-regulation of the Sodium/Iodide Symporter Explains 131I-Induced Thyroid Stunning Cancer Res., August 1, 2007; 67(15): 7512 - 7517. [Abstract] [Full Text] [PDF]

				N. Yeager, A. Klein-Szanto, S. Kimura, and A. Di Cristofano Pten Loss in the Mouse Thyroid Causes Goiter and Follicular Adenomas: Insights into Thyroid Function and Cowden Disease Pathogenesis Cancer Res., February 1, 2007; 67(3): 959 - 966. [Abstract] [Full Text] [PDF]

				J. Behrends, S. Clement, B. Pajak, V. Pohl, C. Maenhaut, J. E. Dumont, and S. Schurmans Normal Thyroid Structure and Function in Rhophilin 2-Deficient Mice Mol. Cell. Biol., April 1, 2005; 25(7): 2846 - 2852. [Abstract] [Full Text] [PDF]

				M. De Felice, M. P. Postiglione, and R. Di Lauro Minireview: Thyrotropin Receptor Signaling in Development and Differentiation of the Thyroid Gland: Insights from Mouse Models and Human Diseases Endocrinology, September 1, 2004; 145(9): 4062 - 4067. [Full Text] [PDF]

				M. Braga-Basaria, E. Hardy, R. Gottfried, K. D. Burman, M. Saji, and M. D. Ringel 17-Allylamino-17-Demethoxygeldanamycin Activity against Thyroid Cancer Cell Lines Correlates with Heat Shock Protein 90 Levels J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2982 - 2988. [Abstract] [Full Text] [PDF]

				J. Wang, J. Grunler, and M. S. Lewitt Gender-Specific Pattern of Insulin-Like Growth Factor-Binding Protein-3 Protease Activity in Mouse Thyroid Endocrinology, March 1, 2004; 145(3): 1137 - 1143. [Abstract] [Full Text] [PDF]

				J.-C. Goffard, L. Jin, H. Mircescu, P. Van Hummelen, C. Ledent, J.-E. Dumont, and B. Corvilain Gene Expression Profile in Thyroid of Transgenic Mice Overexpressing the Adenosine Receptor 2a Mol. Endocrinol., January 1, 2004; 18(1): 194 - 213. [Abstract] [Full Text] [PDF]

				R. C. Marians, L. Ng, H. C. Blair, P. Unger, P. N. Graves, and T. F. Davies Defining thyrotropin-dependent and -independent steps of thyroid hormone synthesis by using thyrotropin receptor-null mice PNAS, November 26, 2002; 99(24): 15776 - 15781. [Abstract] [Full Text] [PDF]